Published 3 days ago • loading... • Updated 3 days ago

WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m

WallachBeth Capital LLC announced that bioAffinity Technologies, Inc. has priced a public offering of securities for aggregate gross proceeds of $4.8 million before deductions.
The closing of the public offering is expected to happen on or about September 30, 2025, pending customary closing conditions.
WallachBeth Capital LLC is acting as the sole placement agent for the offering.
The securities are offered under a registration statement previously filed with the Securities and Exchange Commission.

Insights by Ground AI

36 Articles

WBOC 16

+32 Reposted by 32 other sources

Center

WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m

JERSEY CITY, N.J., Sept. 29, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) a biotechnology company focused on the need for noninvasive…

3 days ago

Read Full Article

Seeking Alpha

Lean Right

bioAffinity Technologies prices $4.8 million public offering; shares down over 30%

bioAffinity Technologies (BIAF) announces $4.8M public offering at $2.50/share. Learn key details and implications for investors.

3 days ago·United States

Read Full Article

stocktitan.net

Cancer Detection Biotech bioAffinity Technologies Raises $4.8M Through Public Offering of 1.9M Shares

bioAffinity Technologies prices public offering of 1.92M shares at $2.50 per share, with pre-funded warrants at $2.493. WallachBeth Capital acts as sole placement agent. Closing expected Sept 30.

3 days ago

Read Full Article